Loading
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Latest filing published 11 Feb 2014 for Revance Therapeutics, Inc..
Insider track record
Disclosed buys
3
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
3
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Essex Woodlands Health Ventures Fund VIII LP: trading record in brief
Filings by Essex Woodlands Health Ventures Fund VIII LP span 3 companies, the busiest being ATS Medical Inc, Complete Genomics Inc and Revance Therapeutics, Inc. The record holds 27 filings, for trades running from 18 December 2009 to 11 February 2014.
No open-market sale appears; the market trades are 3 purchases worth €4.0M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 3 share grants.
The median purchase comes to €261k.
The record was last updated on 11 February 2014 with a transaction in Revance Therapeutics, Inc. The last purchase on record was published on 16 November 2010, which is 5,821 days ago. Publication is fast: at least half of the trades appear on SEC (Form 4) on the same day. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Essex Woodlands Health Ventures Fund VIII LP
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations27 total
2,781,396 sharesCommon StockSEC:0001209191-14-009032:0
43,029 sharesCommon StockSEC:0001209191-14-009032:4
26,605 sharesCommon StockSEC:0001209191-14-009032:5
87,190 sharesCommon StockSEC:0001209191-14-009032:6
18,708 sharesCommon StockSEC:0001209191-14-009032:7
11,560 sharesCommon StockSEC:0001209191-14-009032:8
596,812 sharesCommon StockSEC:0001209191-14-009032:1
369,124 sharesCommon StockSEC:0001209191-14-009032:2
200,538 sharesCommon StockSEC:0001209191-14-009032:3
2,061,134 sharesCommon Stock, par value $0.001SEC:0001181431-10-055850:0
1,159,218 sharesCommon Stock, par value $0.001SEC:0001181431-10-055850:1
546,268 shares@ US$9.00Common Stock, par value $0.001SEC:0001181431-10-055850:2
Canonical exit: 14 Feb 2011 (T+90)
148,608 sharesCommon Stock, par value $0.001SEC:0001181431-10-055850:3
83,580 sharesCommon Stock, par value $0.001SEC:0001181431-10-055850:4
39,386 shares@ US$9.00Common Stock, par value $0.001SEC:0001181431-10-055850:5
Canonical exit: 14 Feb 2011 (T+90)
64,612 sharesCommon Stock, par value $0.001SEC:0001181431-10-055850:6
36,339 sharesCommon Stock, par value $0.001SEC:0001181431-10-055850:7
17,124 shares@ US$9.00Common Stock, par value $0.001SEC:0001181431-10-055850:8
Canonical exit: 14 Feb 2011 (T+90)
8,709,641 sharesCommon StockSEC:0001181431-10-042007:0
627,968 sharesCommon StockSEC:0001181431-10-042007:1
273,030 sharesCommon StockSEC:0001181431-10-042007:2
906,250 shares@ US$2.48Common StockSEC:0001181431-10-032076:0
90,625 shares@ US$2.85Common StockSEC:0001181431-10-032076:1
65,341 shares@ US$2.48Common StockSEC:0001181431-10-032076:2
6,534 shares@ US$2.85Common StockSEC:0001181431-10-032076:3
25 of 27 declarations
